$Northwest Biotherapeutics (NWBO.US)$ Recent updates for Nor...
$Northwest Biotherapeutics (NWBO.US)$ Recent updates for Northwest Biotherapeutics (NWBO) include a significant positive turnout at their Annual Shareholders Meeting, with over 77% of shares voted in favor of key proposals. They also announced an exclusive in-license agreement for a portfolio of dendritic cell technology from Roswell Park Comprehensive Cancer Center, complementing their existing IP. Moreover, NWBO is in the final stages of submitting a Marketing Authorization Application for DCVax®-L in the UK, targeting glioblastoma treatment
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Just a trader who likes stocks, buying high and selling low. 🦧
5Followers
5Following
24Visitors
Follow